体細胞検査

MyChoice® product signature

MyChoice® is the first and only FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status.

詳しくは

MyChoice® is the first and only FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status.

詳しくは

生殖細胞系列検査

BRACAnalysis® product signature

The BRACAnalysis ® test assesses a person’s risk of developing hereditary breast or ovarian cancer based on the detection of mutations in the BRCA1 and BRCA2 genes.

詳しくは

The BRACAnalysis ® test assesses a person’s risk of developing hereditary breast or ovarian cancer based on the detection of mutations in the BRCA1 and BRCA2 genes.

詳しくは

No results found for

Please try changing the search criteria, or reset filters